Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-17

Clinical Trial Update: Impact of Fibroblast Growth Factor 23 (FGF-23) and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients

View source ↗

Summary

The trial explores whether FGF-23 and serum phosphate levels affect allograft function and mortality in kidney transplant recipients; the snippet provides no re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Kidney Transplantation | Status: UNKNOWN